CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Mehiläinen

Kaisla Lahdensuo, Business Director, Specialist Care

Transforming Infertility and Pregnancy Support with Digital Tools

Kaisla Lahdensuo

Kaisla Lahdensuo

Clinical Governance Steward

The stress on health care systems is increasing and there is a need to find smarter ways for taking care of patients. Pandemic has increased the burden as traditional ways for accessing care have been limited. According to our experiences building the digital platform has helped us to facilitate illness prevention and care coordination. The most significant potential has been however in the early intervention. Providing a low threshold for access and a more efficient way for tackling health concerns are the keys to transforming the way we can provide high-quality health care in the future.


We have gained promising feedback by empowering women with digital support. Women face situations that might be worrying including difficulties related to getting pregnant and on the other hand unfamiliar symptoms and concerns related to pregnancy. The Web is getting increasingly popular for searching information. This is providing information overflood and might jeopardize patient safety at worst. The feedback from patients and care personnel has been positive in supporting for example infertility treatment patients. Key elements have been the provision of relevant personalized information of their treatment in a timely manner, reminders of medication and actions, transparency of a woman’s progress and symptoms to the care personnel and low threshold connection to the care personnel.


Building of the digital support for patient journeys such as infertility treatments and pregnancy builds on top of quality focus and patient safety culture.


The leading Swiss healthcare provider Hirslanden is a pioneering example in launching a digitally supported pregnancy journey to facilitate the care coordination of pregnant ladies and give them low threshold access to relevant information, reminders, and access to healthcare professionals for any concerns. Midwives can follow up on the symptoms and progress reported by women. Digital support throughout the pregnancy journey is foreseen to help the Swiss ladies who have suffered from diminishing amount of pregnancy support and services available as live interactions have decreased due to the pandemic. By engaging with the ladies from early on in their pregnancy journey helps to reduce stress, anxiety and prevent potential complications along the way.


Building the digital support for patient journeys such as infertility treatments and pregnancy builds on top of quality focus and patient safety culture. Professionals act based on structured guidelines and platform helps them to support patient safety. By incorporating patient self-reported data and device data with full transparency to the care team and a low threshold for the patient to be in touch we can facilitate better outcomes. On an organizational level, it has also enabled us to develop reporting on aggregated data for quality monitoring and improvement. All in all, we have experienced that digitally enabled patient journeys provide patients a fundamentally different safety net around their health compared to self-help and self-coordinated care with the traditional way.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Healthcare systems are increasingly judged by how consistently they embed quality and safety into everyday clinical decision-making rather than isolated improvement initiatives. This perspective reinforces how governance-led models are becoming central to sustaining trust, accountability and measurable patient outcomes across modern care environments.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/leadership-perspective/kaisla-lahdensuo-nwid-2989.html